Bt. Hill et al., Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1, ANTI-CANC D, 11(3), 2000, pp. 193-200
Failure of chemotherapy is frequently observed in patients previously treat
ed with radiotherapy. To establish a cellular model for examining this resi
stance phenotype a series of mammalian tumor cell lines were exposed in vit
ro to fractionated X-irradiation and were then shown to express resistance
to multiple antitumor drugs, including vincristine, etoposide and cisplatin
, In these experiments the radiation was delivered as 10 fractions of 5 Gy
(dose resulting in 1 log cell kill) given intermittently over several month
s. We now report that a comparable multidrug-resistance profile is expresse
d by human SK-OV-3 human ovarian tumor cells exposed in vitro to low dose (
2 Gy) twice-daily fractions of Xrays given for 5 days on two consecutive we
eks, essentially mimicking clinical practice, involving an overexpression o
f two Mop-associated proteins, P-glycoprotein and the multidrug resistance
protein 1 (MRP1), with the latter being readily detectable by immunocytoche
mistry, [(C) 2000 Lippincott Williams & Wilkins.].